NOT KNOWN FACTS ABOUT WHO MAKES WEGOVY AND COPYRIGHT

U.S. pharma giant copyright scrapped two experimental weight loss drugs last year—a as soon as-everyday tablet, lotiglipron, due to elevated liver enzymes along with a 2 times-daily pill, danuglipron, resulting from solid Unwanted effects—but CEO Albert Bourla has claimed the company is decided to “Perform and gain” in the being overweight